株式会社Veritas In SilicoTSE 130A

株式会社Veritas In Silico · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥17.8M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 中村 慎吾 1,400,000 21.60% — —
2 Mitsubishi Gas Chemical Co., Ltd. 731,256 11.30% — —
3 New Life Science1号投資事業有限責任組合 556,444 8.60% — —
4 三菱UFJライフサイエンス1号投資事業有限責任組合 512,640 7.90% — —
5 IEファスト&エクセレント投資事業有限責任組合 331,700 5.10% — —
6 梨本 正之 298,390 4.60% — —
7 楽天証券株式会社 131,900 2.00% — —
8 Nomura PB Nominees Limited Omnibus-Margin 116,900 1.80% — —
9 みずほライフサイエンス第1号投資事業有限責任組合 75,200 1.20% — —
10 株式会社SBI証券 61,423 0.90% — —

Officers' holdings and pay

NameTitleSharesValuePay
中村 慎吾 President & Representative Director 1,400,000 — —
萩原 宏昭 Director 400 — —
甲田 伊佐男 Director 1,400 — —
小南 欽一郎 Director 1,610 — —
鈴木 貞雄 Full-time Audit & Supervisory Board Member 900 — —
廣岡 穣 Audit & Supervisory Board Member 400 — —
若林 美奈子 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-65.62 — — 6,487,114
FY ending Dec 2024 — ¥-37.11 — — 6,487,114
Source: annual securities reports on EDINET. Values are estimates. Methodology